Abstract
The previous diabetic arteriovenous fistula animal model indicates improved flow dynamics with the use of HMG-CoA-reductase inhibitors (statins). We have reported on few thrombosis events in patients on statins who had successful cannulation of their radiocephalic arteriovenous fistula. We predict similar favorable outcomes in diabetic patients undergoing arteriovenous graft (AVG) placements.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
